A case of hepatitis E that developed during chemotherapy for malignant lymphoma and responded to ribavirin

A case of hepatitis E that developed during chemotherapy for malignant lymphoma and responded to ribavirin

Abstract Background The main differences in cases of sudden elevation of hepatic enzyme levels during immunochemotherapy are the reactivation of the hepatitis B virus or drug‐induced liver injury. Here, we report a case of acute liver injury caused by the hepatitis E virus (HEV) during chemotherapy...

Full description

Bibliographic Details
Main Authors: Seiya Hashimoto, Hirofumi Fukuda, Kohei Takeda, Keiichi Uchida, Fumiaki Sanuki, Takashi Akiyama, Eisei Kondo, Hideho Wada
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Cancer Reports
Subjects:
chemotherapy
hepatitis E virus
ribavirin
Online Access:https://doi.org/10.1002/cnr2.1957

Similar Items

Similar Items